Denosumab (Prolia) for the treatment of osteoporosis
Moshi M, Nicolopoulos K, Gaget V, Ampofo A, Ma N, Vreugdenburg T
Record ID 32018004605
English
Details
Project Status:
Completed
Year Published:
2022
URL for published report:
https://www.bag.admin.ch/dam/bag/en/dokumente/kuv-leistungen/leistungen-und-tarife/hta/berichte/h0039deno-hta-report.pdf.download.pdf/h0039deno-hta-report.pdf
Requestor:
Federal Office of Public Health.
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Bone Density
- Bone Density Conservation Agents
- Osteoporosis
- Denosumab
- Diphosphonates
- Selective Estrogen Receptor Modulators
- Neoplasms
- Ibandronic Acid
- Hormones
- Risedronic Acid
- Zoledronic Acid
Contact
Organisation Name:
Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
Contact Address:
ASERNIP-S 24 King William Street, Kent Town SA 5067 Australia Tel: +61 8 8219 0900
Contact Name:
racs.asernip@surgeons.org
Contact Email:
racs.asernip@surgeons.org
Copyright:
Australian Safety and Efficacy Register of New Interventional Procedures - Surgical
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.